Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock (right to buy) | 2.44M | Feb 13, 2024 | By Trust | ||
Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1.9M | Feb 13, 2024 | By Trust | ||
Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 1.37M | Feb 13, 2024 | Indirect | ||
MIRA PHARMACEUTICALS, INC. | 10%+ Owner | Common Stock Warrant (right to buy) | 700K | Nov 15, 2023 | Indirect | ||
Telomir Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 24.4K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TELO | Telomir Pharmaceuticals, Inc. | Feb 13, 2024 | 3 | $966K | 4 | Feb 15, 2024 | 10%+ Owner |
TELO | Telomir Pharmaceuticals, Inc. | Feb 8, 2024 | 0 | $0 | 3 | Feb 8, 2024 | 10%+ Owner |
MIRA | MIRA PHARMACEUTICALS, INC. | Nov 15, 2023 | 1 | $0 | 4 | Nov 17, 2023 | 10%+ Owner |